Caricamento...
A tertiary care audit of using abiraterone acetate in patients of metastatic castrate-resistant prostate cancer
INTRODUCTION: This is a retrospective analysis to assess the safety and efficacy of abiraterone acetate (AA) in metastatic castrate-resistant prostate cancer (mCRPC) patients treated at tertiary care institute. MATERIALS AND METHODS: The clinical records of mCRPC patients treated with AA at our tert...
Salvato in:
| Pubblicato in: | South Asian J Cancer |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wolters Kluwer - Medknow
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6956584/ https://ncbi.nlm.nih.gov/pubmed/31956615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/sajc.sajc_433_18 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|